LOGC · Contextlogic Inc

-

Please sign in to comment on LOGC

1 Comment

Admin

4 years ago

LogicBio Therapeutics, Inc is currently in a long term downtrend where the price is trading 38.2% below its 200 day moving average.

From a valuation standpoint, the stock is 96.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 52.6.

LogicBio Therapeutics, Inc's total revenue rose by inf% to $542K since the same quarter in the previous year.

Its net income has increased by 39.8% to $-7M since the same quarter in the previous year.

Finally, its free cash flow grew by 36.7% to $-8M since the same quarter in the previous year.

Based on the above factors, LogicBio Therapeutics, Inc gets an overall score of 4/5.

Exchange	NASDAQ
CurrencyCode	USD
ISIN	US21077C1071
Sector	Consumer Cyclical
Industry	Internet Retail

Beta	2.0
Target Price	5.9
Market Cap	184M
PE Ratio	None
Dividend Yield	None

ABOUT

Contextlogic Inc

ContextLogic Inc. does not have significant operations. It focuses on identifying, evaluating, and executing strategic opportunities. Previously, it was engaged in the marketplace and logistics business operations. ContextLogic Inc. was incorporated in 2010 and is headquartered in Oakland, California.

LOGC · Contextlogic Inc

-

Contextlogic Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Contextlogic Inc using a moving average strategy